Antunes Filipe, Airosa Emanuel, Rubio Rodriguez Samara, Faria Igor, Anes Diogo, Cruz Teresa, Oliveira José Miguel, Simões João, Dias Lisandra, Faria Carina, Xavier Pedro, Alves Patrícia, Pereira Jacinta, Lima Inês, Marques Pereira Raul
Physical and Rehabilitation Medicine Department and Chronic Pain Functional Unit, Braga Hospital, Braga, Portugal.
Unidade de Saúde Familiar Terra da Nóbrega, Vila Verde, Portugal.
Future Sci OA. 2025 Dec;11(1):2527503. doi: 10.1080/20565623.2025.2527503. Epub 2025 Aug 11.
The REGENERAR registry study aimed to assess the prevalence of pain among Diabetic Peripheral Neuropathy (DPN) patients and to evaluate their health literacy and quality of life.
REGENERAR was a prospective, multicentric registry study conducted in primary healthcare units across Portugal. Adults with DPN were enrolled between April and September 2023. Sociodemographic and clinical information, including pain, neuropathic pain, literacy and quality of life were collected at inclusion visit (V1) and end-of-study visit (V2).
The study enrolled 127 patients, 120 of whom completed V2. At V1, 77.5% of participants reported pain (61.7% at V2, p < 0.001), with neuropathic pain prevalence, assessed by clinical findings and result of DN4 questionnaire, being 48.3% at V1 and 46.7% at V2. Patient literacy on pain as a diabetes symptom improved from V1 to V2. Quality of life remained stable but suboptimal, with a median score of 70/100 on the EQ-5D-5L scale.
The REGENERAR registry highlights a high prevalence of pain among DPN patients in Portugal, exceeding international figures, but consistent with literature concerning neuropathic pain. It also identifies critical gaps in both patient and healthcare provider literacy. Addressing these gaps could improve disease management and quality of life.
REGENERAR注册研究旨在评估糖尿病周围神经病变(DPN)患者的疼痛患病率,并评估他们的健康素养和生活质量。
REGENERAR是一项在葡萄牙各地基层医疗单位开展的前瞻性多中心注册研究。2023年4月至9月纳入了患有DPN的成年人。在纳入访视(V1)和研究结束访视(V2)时收集社会人口统计学和临床信息,包括疼痛、神经性疼痛、素养和生活质量。
该研究共纳入127例患者,其中120例完成了V2访视。在V1访视时,77.5%的参与者报告有疼痛(V2访视时为61.7%,p<0.001),根据临床检查结果和DN4问卷结果评估的神经性疼痛患病率在V1访视时为48.3%,在V2访视时为46.7%。患者对疼痛作为糖尿病症状的认知从V1到V2有所改善。生活质量保持稳定但不理想,在EQ-5D-5L量表上的中位数得分为70/100。
REGENERAR注册研究突出显示葡萄牙DPN患者的疼痛患病率很高,超过国际数据,但与有关神经性疼痛的文献一致。它还发现了患者和医疗服务提供者在认知方面的关键差距。解决这些差距可能会改善疾病管理和生活质量。